Emmaus Life Sciences, Inc. (EMMA) stock
EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05−0.01 (-14.38%)
Close on Oct 19, 2026Market cap $6.03MP/E –Yield –
Emmaus Life Sciences cash
Cash and short-term investments held at the end of each period.
Emmaus Life Sciences's cash was $2.81M at Jun 30, 2026. For fiscal 2025 it was $2.13M, up 53.1% from the year before. Over ten years it grew 5.5% a year on average. The highest annual figure on record is $29.70M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.13M | +53.1% |
| FY2024 | Dec 31, 2024 | $1.39M | -45.5% |
| FY2023 | Dec 31, 2023 | $2.55M | +26.0% |
| FY2022 | Dec 31, 2022 | $2.02M | -11.3% |
| FY2021 | Dec 31, 2021 | $2.28M | -8.4% |
| FY2020 | Dec 31, 2020 | $2.49M | -91.6% |
| FY2019 | Dec 31, 2019 | $29.70M | +445.0% |
| FY2017 | Sep 30, 2017 | $5.45M | +1612.4% |
| FY2016 | Sep 30, 2016 | $318.20K | -26.4% |
| FY2015 | Sep 30, 2015 | $432.10K | -65.2% |
| FY2014 | Sep 30, 2014 | $1.24M | -2.6% |
| FY2013 | Sep 30, 2013 | $1.27M | +16440.3% |
| FY2012 | Sep 30, 2012 | $7.70K | -89.5% |
| FY2011 | Sep 30, 2011 | $73.60K | +32.9% |
| FY2010 | Sep 30, 2010 | $55.40K | -94.4% |
| FY2009 | Sep 30, 2009 | $988.10K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $2.81M | +216.9% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $1.07M | -22.8% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $2.13M | +69.5% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $293.00K | -80.8% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $886.00K | -48.2% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $1.39M | -45.5% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $1.26M | -16.6% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $1.53M | +12.0% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $1.71M | -3.5% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $2.55M | +26.0% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $1.51M | +27.7% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $1.36M | +38.6% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $1.77M | +118.2% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $2.02M | -11.3% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $1.18M | -49.2% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $982.00K | -41.2% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $813.00K | -78.4% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $2.28M | -8.4% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $2.32M | -53.1% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $1.67M | -94.0% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $3.76M | -89.8% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $2.49M | -91.6% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $4.95M | -86.2% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $28.04M | -37.8% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $36.98M | +578.7% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $29.70M | +7155.8% |
| Q3 FY2019CQ3 2018 | Jun 30, 2019 | $35.84M | +1942.7% |
| Q2 FY2019CQ2 2018 | Mar 31, 2019 | $45.11M | +4203.0% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $5.45M | +1612.4% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $409.30K | -5.0% |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $1.75M | +298.5% |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $1.05M | +27.3% |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $318.20K | -26.4% |
| Q3 FY2016CQ2 2016 | Jun 30, 2016 | $430.80K | +203.8% |
| Q2 FY2016CQ1 2016 | Mar 31, 2016 | $440.20K | +42.0% |
| Q1 FY2016CQ4 2015 | Dec 31, 2015 | $823.80K | +84.8% |
| Q4 FY2015CQ3 2015 | Sep 30, 2015 | $432.10K | – |
| Q3 FY2015CQ2 2015 | Jun 30, 2015 | $141.80K | – |
| Q2 FY2015CQ1 2015 | Mar 31, 2015 | $310.00K | – |
| Q1 FY2015CQ4 2014 | Dec 31, 2014 | $445.70K | – |
See a number that looks wrong?